BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22537749)

  • 21. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
    Baniasadi V; Narain N; Goswami R; Das SN
    Tissue Antigens; 2006 May; 67(5):383-9. PubMed ID: 16671945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
    Balic I; Angel B; Codner E; Carrasco E; Pérez-Bravo F
    Hum Immunol; 2009 Feb; 70(2):116-20. PubMed ID: 19136037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults.
    Novota P; Kolostova K; Pinterova D; Novak J; Treslova L; Andel M; Cerna M
    Immunol Lett; 2005 Jan; 96(2):247-51. PubMed ID: 15585330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [-174 G/C polymorphism of interleukin 6 gene in women with type 1 diabetes].
    Pérez-Bravo F; Soto M F; López A P; Eyzaguirre C F; Codner E
    Rev Med Chil; 2011 Feb; 139(2):158-64. PubMed ID: 21773651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2006 Jun; 7():54. PubMed ID: 16796743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 18 (IL18) gene promoter polymorphisms are associated with type 1 diabetes mellitus in Brazilian patients.
    Tavares NA; Santos MM; Moura R; Araújo J; Guimarães R; Crovella S; Brandão L
    Cytokine; 2013 May; 62(2):286-9. PubMed ID: 23557801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children.
    Aittoniemi J; Turpeinen H; Tiittanen M; Knip M; Simell O; Ilonen J; Vaarala O
    Hum Immunol; 2008 Feb; 69(2):108-11. PubMed ID: 18361935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTLA4 promoter polymorphisms are associated with canine diabetes mellitus.
    Short AD; Saleh NM; Catchpole B; Kennedy LJ; Barnes A; Jones CA; Fretwell N; Ollier WE
    Tissue Antigens; 2010 Mar; 75(3):242-52. PubMed ID: 20196832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene.
    Zalloua PA; Abchee A; Shbaklo H; Zreik TG; Terwedow H; Halaby G; Azar ST
    Hum Immunol; 2004 Jul; 65(7):719-24. PubMed ID: 15301861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of BANK1 and cytokine gene polymorphisms with type 1 diabetes in Tunisia.
    Zouidi F; Stayoussef M; Bouzid D; Fourati H; Abida O; João C; Ayed MB; Fakhfakh R; Thouraya K; Monjia H; Carlos PG; Masmoudi H
    Gene; 2014 Feb; 536(2):296-301. PubMed ID: 24342660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
    Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes.
    Mojtahedi Z; Naeimi S; Farjadian S; Omrani GR; Ghaderi A
    Diabet Med; 2006 Mar; 23(3):235-9. PubMed ID: 16492204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2007 Aug; 8():54. PubMed ID: 17697317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy.
    Ma J; Möllsten A; Prázny M; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
    Diabet Med; 2006 Oct; 23(10):1093-9. PubMed ID: 16978373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic evaluation of the TNF-α -238G>A and -308G>A promoter polymorphisms in Croatian patients with type I diabetes.
    Korolija M; Hadžija M; Medvidović EP; Pavkovic P; Kapitanović S; Renar IP; Hadžija MP
    Hum Immunol; 2010 Dec; 71(12):1228-32. PubMed ID: 20849900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5.
    Shin JH; Janer M; McNeney B; Blay S; Deutsch K; Sanjeevi CB; Kockum I; Lernmark A; Graham J; ; ; Arnqvist H; Björck E; Eriksson J; Nyström L; Ohlson LO; Scherstén B; Ostman J; Aili M; Bååth LE; Carlsson E; Edenwall H; Forsander G; Granström BW; Gustavsson I; Hanås R; Hellenberg L; Hellgren H; Holmberg E; Hörnell H; Ivarsson SA; Johansson C; Jonsell G; Kockum K; Lindblad B; Lindh A; Ludvigsson J; Myrdal U; Neiderud J; Segnestam K; Sjöblad S; Skogsberg L; Strömberg L; Ståhle U; Thalme B; Tullus K; Tuvemo T; Wallensteen M; Westphal O; Aman J
    Genes Immun; 2007 Sep; 8(6):503-12. PubMed ID: 17641683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel.
    Benedek G; Brautbar C; Vardi P; Sharon N; Weintrob N; Zung A; Israel S
    Tissue Antigens; 2009 Jan; 73(1):33-8. PubMed ID: 19000139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
    Aminkeng F; Van Autreve JE; Koeleman BP; Quartier E; Van Schravendijk C; Gorus FK; Van der Auwera BJ;
    Hum Immunol; 2007 Aug; 68(8):690-7. PubMed ID: 17678725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.